Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins for Left Ventricular Hypertrophy Reduction in Hypertensive Patients
NCT00738972Phase 3Terminated
- Sponsor
- Fundación Lindavista del Corazón
- Start
- Jan 2008
- Primary completion
- Aug 2010
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
A Phase 3 trial of Vytorin in left ventricular hypertrophy (LVH), sponsored by Fundación Lindavista del Corazón. Started Jan 2008; status: terminated.
02
Drugs
Vytorin
03
Conditions
left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT00738972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738972.